Guerra Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Guerra Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$100	Buy	+1	New	+$90	﹤0.01%	881

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Guerra Advisors's XBI Position: Q3 2025 in Review

Guerra Advisors opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q3 2025: 1 share worth $100. The stake represents ﹤0.01% of the portfolio and ranks #881 among its holdings.

656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

Guerra Advisors held 1 share of State Street SPDR S&P Biotech ETF worth $100 as of Q3 2025.
State Street SPDR S&P Biotech ETF was a new Guerra Advisors position in Q3 2025.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Guerra Advisors's portfolio in Q3 2025, its #881 holding.
656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on Guerra Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.